Skip to main content
Erschienen in: Pediatric Cardiology 1/2020

01.01.2020 | Review Article

Genetic Contribution to Congenital Heart Disease (CHD)

verfasst von: NA Shabana, Saleem Ullah Shahid, Uzma Irfan

Erschienen in: Pediatric Cardiology | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Congenital heart defects (CHD) are the most common congenital problems in neonates. The basis for CHD is multifactorial, involving genetic and environmental components. The elucidation of genetic components remains difficult because it is a genetically heterogeneous disease. Currently, the major identified genetic causes include chromosomal abnormalities, large subchromosomal deletions/duplications, and point mutations. However, much more remains to be unraveled. An important insight from the research on the genetics of CHD is that any change at the genetic level that alters the dosage of genes required in any process during heart development results in a developmental defect. The use of conventional gene identification (linkage analysis and direct targeted sequencing) methods followed by the rapid advancements in high-throughput technologies (copy number variant platforms, SNP arrays, and next-generation sequencing) has identified an extensive list of genetic causes. However, the most common presentation of CHD is in the form of sporadic cases. Therefore, it is important to identify their underlying genetic cause. In this review, we revisit the causal genetic factors of CHD and discuss the clinical implications of research in the field.
Literatur
1.
Zurück zum Zitat Hoffman JI, Kaplan S (2002) The incidence of congenital heart disease. J Am Coll Cardiol 39(12):1890–1900PubMedCrossRef Hoffman JI, Kaplan S (2002) The incidence of congenital heart disease. J Am Coll Cardiol 39(12):1890–1900PubMedCrossRef
2.
Zurück zum Zitat Pate N, Jawed S, Nigar N, Junaid F, Wadood AA, Abdullah F (2016) Frequency and pattern of congenital heart defects in a tertiary care cardiac hospital of Karachi. Pak J Med Sci. 32(1):79PubMedPubMedCentral Pate N, Jawed S, Nigar N, Junaid F, Wadood AA, Abdullah F (2016) Frequency and pattern of congenital heart defects in a tertiary care cardiac hospital of Karachi. Pak J Med Sci. 32(1):79PubMedPubMedCentral
3.
Zurück zum Zitat Mendis S, Puska P, Norrving B. Global atlas on cardiovascular disease prevention and control: World Health Organization; 2011. Mendis S, Puska P, Norrving B. Global atlas on cardiovascular disease prevention and control: World Health Organization; 2011.
4.
Zurück zum Zitat Hersh JH, Angle B, Fox TL, Barth RF, Bendon RW, Gowans G (2002) Developmental field defects: coming together of associations and sequences during blastogenesis. Am J Med Genet Part A. 110(4):320–323CrossRef Hersh JH, Angle B, Fox TL, Barth RF, Bendon RW, Gowans G (2002) Developmental field defects: coming together of associations and sequences during blastogenesis. Am J Med Genet Part A. 110(4):320–323CrossRef
5.
Zurück zum Zitat Franklin RC, Jacobs JP, Tchervenkov CI, Béland MJ (2002) Bidirectional crossmap of the Short Lists of the European Paediatric Cardiac Code and the International Congenital Heart Surgery Nomenclature and Database Project. Cardiol Young 12(S2):18–22CrossRef Franklin RC, Jacobs JP, Tchervenkov CI, Béland MJ (2002) Bidirectional crossmap of the Short Lists of the European Paediatric Cardiac Code and the International Congenital Heart Surgery Nomenclature and Database Project. Cardiol Young 12(S2):18–22CrossRef
6.
7.
Zurück zum Zitat Gilboa SM, Devine OJ, Kucik JE, Oster ME, Riehle-Colarusso T, Nembhard WN et al (2016) Congenital heart defects in the United States. Circulation 134(2):101–109PubMedPubMedCentralCrossRef Gilboa SM, Devine OJ, Kucik JE, Oster ME, Riehle-Colarusso T, Nembhard WN et al (2016) Congenital heart defects in the United States. Circulation 134(2):101–109PubMedPubMedCentralCrossRef
8.
Zurück zum Zitat Jacobson B. Circulatory Changes at Birth. Embryo Project Encyclopedia. 2012. Jacobson B. Circulatory Changes at Birth. Embryo Project Encyclopedia. 2012.
9.
Zurück zum Zitat Poglavlja O. Robbins and Cotran Pathologic Basis of Disease 8th Edition. Poglavlja O. Robbins and Cotran Pathologic Basis of Disease 8th Edition.
10.
Zurück zum Zitat Maillet M, Van Berlo JH, Molkentin JD (2013) Molecular basis of physiological heart growth: fundamental concepts and new players. Nat Rev Mol Cell Biol 14(1):38PubMedPubMedCentralCrossRef Maillet M, Van Berlo JH, Molkentin JD (2013) Molecular basis of physiological heart growth: fundamental concepts and new players. Nat Rev Mol Cell Biol 14(1):38PubMedPubMedCentralCrossRef
11.
Zurück zum Zitat Shahzad M, Waqar T, Waheed KAI, Gul R, Fatima ST (2017) Pulse oximetry as a screening tool for critical congenital heart defects in newborns. JPMA J Pak Med Ass. 67(8):1220 Shahzad M, Waqar T, Waheed KAI, Gul R, Fatima ST (2017) Pulse oximetry as a screening tool for critical congenital heart defects in newborns. JPMA J Pak Med Ass. 67(8):1220
12.
Zurück zum Zitat Fahed AC, Gelb BD, Seidman J, Seidman CE (2013) Genetics of Congenital Heart Disease. Circ Res. 112(4):707–720PubMedCrossRef Fahed AC, Gelb BD, Seidman J, Seidman CE (2013) Genetics of Congenital Heart Disease. Circ Res. 112(4):707–720PubMedCrossRef
13.
Zurück zum Zitat Blalock A, Taussig HB (1945) The surgical treatment of malformations of the heart: in which there is pulmonary stenosis or pulmonary atresia. J Am Med Assoc 128(3):189–202CrossRef Blalock A, Taussig HB (1945) The surgical treatment of malformations of the heart: in which there is pulmonary stenosis or pulmonary atresia. J Am Med Assoc 128(3):189–202CrossRef
14.
Zurück zum Zitat Marelli AJ, Ionescu-Ittu R, Mackie AS, Guo L, Dendukuri N, Kaouache M. Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010. Circulation. 2014:CIRCULATIONAHA. 113.008396. Marelli AJ, Ionescu-Ittu R, Mackie AS, Guo L, Dendukuri N, Kaouache M. Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010. Circulation. 2014:CIRCULATIONAHA. 113.008396.
15.
Zurück zum Zitat Kopf PG, Walker MK (2009) Overview of developmental heart defects by dioxins, PCBs, and pesticides. Journal of Environmental Science and Health, Part C 27(4):276–285CrossRef Kopf PG, Walker MK (2009) Overview of developmental heart defects by dioxins, PCBs, and pesticides. Journal of Environmental Science and Health, Part C 27(4):276–285CrossRef
16.
Zurück zum Zitat Zhu H, Kartiko S, Finnell R (2009) Importance of gene–environment interactions in the etiology of selected birth defects. Clin Genet. 75(5):409–423PubMedCrossRef Zhu H, Kartiko S, Finnell R (2009) Importance of gene–environment interactions in the etiology of selected birth defects. Clin Genet. 75(5):409–423PubMedCrossRef
17.
Zurück zum Zitat Fahed A, Gelb B, Seidman J, Seidman C. Genetics of congenital heart disease: the glass half empty (vol 112, pg 707, 2013). Circulation research. 2013;112(12):E182-E.PubMedCrossRef Fahed A, Gelb B, Seidman J, Seidman C. Genetics of congenital heart disease: the glass half empty (vol 112, pg 707, 2013). Circulation research. 2013;112(12):E182-E.PubMedCrossRef
18.
Zurück zum Zitat van der Linde D, Konings EE, Slager MA, Witsenburg M, Helbing WA, Takkenberg JJ et al (2011) Birth prevalence of congenital heart disease worldwide. J Am Coll Cardiol 58(21):2241–2247PubMedCrossRef van der Linde D, Konings EE, Slager MA, Witsenburg M, Helbing WA, Takkenberg JJ et al (2011) Birth prevalence of congenital heart disease worldwide. J Am Coll Cardiol 58(21):2241–2247PubMedCrossRef
19.
Zurück zum Zitat Nora JJ, Dodd PF, McNamara DG, Hattwick MA, Leachman RD, Cooley DA (1969) Risk to offspring of parents with congenital heart defects. JAMA 209(13):2052–2053PubMedCrossRef Nora JJ, Dodd PF, McNamara DG, Hattwick MA, Leachman RD, Cooley DA (1969) Risk to offspring of parents with congenital heart defects. JAMA 209(13):2052–2053PubMedCrossRef
20.
Zurück zum Zitat Øyen N, Poulsen G, Boyd HA, Wohlfahrt J, Jensen PK, Melbye M (2009) Recurrence of congenital heart defects in families. Circulation 120(4):295–301PubMedCrossRef Øyen N, Poulsen G, Boyd HA, Wohlfahrt J, Jensen PK, Melbye M (2009) Recurrence of congenital heart defects in families. Circulation 120(4):295–301PubMedCrossRef
22.
Zurück zum Zitat Shieh JT, Bittles AH, Hudgins L (2012) Consanguinity and the risk of congenital heart disease. Am J Med Genet Part A. 158(5):1236–1241CrossRef Shieh JT, Bittles AH, Hudgins L (2012) Consanguinity and the risk of congenital heart disease. Am J Med Genet Part A. 158(5):1236–1241CrossRef
24.
Zurück zum Zitat Basson CT, Cowley GS, Solomon SD, Weissman B, Poznanski AK, Traill TA et al (1994) The clinical and genetic spectrum of the Holt-Oram syndrome (heart-hand syndrome). N Engl J Med. 330(13):885–891PubMedCrossRef Basson CT, Cowley GS, Solomon SD, Weissman B, Poznanski AK, Traill TA et al (1994) The clinical and genetic spectrum of the Holt-Oram syndrome (heart-hand syndrome). N Engl J Med. 330(13):885–891PubMedCrossRef
25.
Zurück zum Zitat McGregor TL, Misri A, Bartlett J, Orabona G, Friedman RD, Sexton D et al (2010) Consanguinity mapping of congenital heart disease in a South Indian population. PLoS ONE 5(4):e10286PubMedPubMedCentralCrossRef McGregor TL, Misri A, Bartlett J, Orabona G, Friedman RD, Sexton D et al (2010) Consanguinity mapping of congenital heart disease in a South Indian population. PLoS ONE 5(4):e10286PubMedPubMedCentralCrossRef
26.
Zurück zum Zitat Wooten EC, Iyer LK, Montefusco MC, Hedgepeth AK, Payne DD, Kapur NK et al (2010) Application of gene network analysis techniques identifies AXIN1/PDIA2 and endoglin haplotypes associated with bicuspid aortic valve. PLoS ONE 5(1):e8830PubMedPubMedCentralCrossRef Wooten EC, Iyer LK, Montefusco MC, Hedgepeth AK, Payne DD, Kapur NK et al (2010) Application of gene network analysis techniques identifies AXIN1/PDIA2 and endoglin haplotypes associated with bicuspid aortic valve. PLoS ONE 5(1):e8830PubMedPubMedCentralCrossRef
27.
Zurück zum Zitat Keavney B, Mamasoula C, Hall D, Topf A, Griffin H, Rahman T, et al. A Common Variant in the PTPN11 Gene Contributes to the Risk of Tetralogy of Fallot. Am Heart Assoc; 2011. Keavney B, Mamasoula C, Hall D, Topf A, Griffin H, Rahman T, et al. A Common Variant in the PTPN11 Gene Contributes to the Risk of Tetralogy of Fallot. Am Heart Assoc; 2011.
28.
Zurück zum Zitat Hartman RJ, Rasmussen SA, Botto LD, Riehle-Colarusso T, Martin CL, Cragan JD et al (2011) The contribution of chromosomal abnormalities to congenital heart defects: a population-based study. Pediatr Cardiol. 32(8):1147–1157PubMedCrossRef Hartman RJ, Rasmussen SA, Botto LD, Riehle-Colarusso T, Martin CL, Cragan JD et al (2011) The contribution of chromosomal abnormalities to congenital heart defects: a population-based study. Pediatr Cardiol. 32(8):1147–1157PubMedCrossRef
29.
Zurück zum Zitat Antonarakis SE, Lyle R, Dermitzakis ET, Reymond A, Deutsch S (2004) Chromosome 21 and down syndrome: from genomics to pathophysiology. Nat Rev Genet. 5(10):725–738PubMedCrossRef Antonarakis SE, Lyle R, Dermitzakis ET, Reymond A, Deutsch S (2004) Chromosome 21 and down syndrome: from genomics to pathophysiology. Nat Rev Genet. 5(10):725–738PubMedCrossRef
30.
Zurück zum Zitat Bondy CA (2009) Turner syndrome 2008. Hormone Research in Paediatrics. 71(Suppl. 1):52–56CrossRef Bondy CA (2009) Turner syndrome 2008. Hormone Research in Paediatrics. 71(Suppl. 1):52–56CrossRef
31.
Zurück zum Zitat Pont SJ, Robbins JM, Bird T, Gibson JB, Cleves MA, Tilford JM et al (2006) Congenital malformations among liveborn infants with trisomies 18 and 13. Am J Med Genet Part A. 140(16):1749–1756PubMedCrossRef Pont SJ, Robbins JM, Bird T, Gibson JB, Cleves MA, Tilford JM et al (2006) Congenital malformations among liveborn infants with trisomies 18 and 13. Am J Med Genet Part A. 140(16):1749–1756PubMedCrossRef
32.
Zurück zum Zitat Wimalasundera R, Gardiner H (2004) Congenital heart disease and aneuploidy. Prenat Diagn. 24(13):1116–1122PubMedCrossRef Wimalasundera R, Gardiner H (2004) Congenital heart disease and aneuploidy. Prenat Diagn. 24(13):1116–1122PubMedCrossRef
33.
Zurück zum Zitat Grossman TR, Gamliel A, Wessells RJ, Taghli-Lamallem O, Jepsen K, Ocorr K et al (2011) Over-expression of DSCAM and COL6A2 cooperatively generates congenital heart defects. PLoS Genet. 7(11):e1002344PubMedPubMedCentralCrossRef Grossman TR, Gamliel A, Wessells RJ, Taghli-Lamallem O, Jepsen K, Ocorr K et al (2011) Over-expression of DSCAM and COL6A2 cooperatively generates congenital heart defects. PLoS Genet. 7(11):e1002344PubMedPubMedCentralCrossRef
34.
35.
Zurück zum Zitat Glessner J, Bick AG, Ito K, Homsy J, Rodriguez-Murillo L, Fromer M, et al. Increased frequency of de novo copy number variations in congenital heart disease by integrative analysis of SNP array and exome sequence data. Circ Res. 2014:CIRCRESAHA. 114.304458. Glessner J, Bick AG, Ito K, Homsy J, Rodriguez-Murillo L, Fromer M, et al. Increased frequency of de novo copy number variations in congenital heart disease by integrative analysis of SNP array and exome sequence data. Circ Res. 2014:CIRCRESAHA. 114.304458.
36.
Zurück zum Zitat Merscher S, Funke B, Epstein JA, Heyer J, Puech A, Lu MM et al (2001) TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell 104(4):619–629PubMedCrossRef Merscher S, Funke B, Epstein JA, Heyer J, Puech A, Lu MM et al (2001) TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell 104(4):619–629PubMedCrossRef
37.
Zurück zum Zitat Pehlivan T, Pober BR, Brueckner M, Garrett S, Slaugh R, Van Rheeden R, et al. GATA4 haploinsufficiency in patients with interstitial deletion of chromosome region 8p23. 1 and congenital heart disease. Am J Med Genet Part A. 1999;83(3):201–6.PubMedCrossRef Pehlivan T, Pober BR, Brueckner M, Garrett S, Slaugh R, Van Rheeden R, et al. GATA4 haploinsufficiency in patients with interstitial deletion of chromosome region 8p23. 1 and congenital heart disease. Am J Med Genet Part A. 1999;83(3):201–6.PubMedCrossRef
38.
Zurück zum Zitat Nickerson E, Greenberg F, Keating MT, McCaskill C, Shaffer LG. Deletions of the elastin gene at 7q11. 23 occur in approximately 90% of patients with Williams syndrome. Am J Hum Genet. 1995;56(5):1156. Nickerson E, Greenberg F, Keating MT, McCaskill C, Shaffer LG. Deletions of the elastin gene at 7q11. 23 occur in approximately 90% of patients with Williams syndrome. Am J Hum Genet. 1995;56(5):1156.
39.
Zurück zum Zitat Ye M, Coldren C, Liang X, Mattina T, Goldmuntz E, Benson DW et al (2009) Deletion of ETS-1, a gene in the Jacobsen syndrome critical region, causes ventricular septal defects and abnormal ventricular morphology in mice. Hum Mol Genet. 19(4):648–656PubMedPubMedCentralCrossRef Ye M, Coldren C, Liang X, Mattina T, Goldmuntz E, Benson DW et al (2009) Deletion of ETS-1, a gene in the Jacobsen syndrome critical region, causes ventricular septal defects and abnormal ventricular morphology in mice. Hum Mol Genet. 19(4):648–656PubMedPubMedCentralCrossRef
40.
Zurück zum Zitat Ta-Shma A, Frumkin A, Rein AJ, Yaacov B, Werner M, Elpeleg O et al (2014) A human laterality disorder associated with a homozygous WDR16 deletion. Eur J Hum Genet. 23(9):1262PubMedPubMedCentralCrossRef Ta-Shma A, Frumkin A, Rein AJ, Yaacov B, Werner M, Elpeleg O et al (2014) A human laterality disorder associated with a homozygous WDR16 deletion. Eur J Hum Genet. 23(9):1262PubMedPubMedCentralCrossRef
41.
Zurück zum Zitat Andreassi MG, Della CA (2016) Genetics of bicuspid aortic valve aortopathy. Curr Opin Cardiol. 31(6):585–592PubMedCrossRef Andreassi MG, Della CA (2016) Genetics of bicuspid aortic valve aortopathy. Curr Opin Cardiol. 31(6):585–592PubMedCrossRef
42.
Zurück zum Zitat Soemedi R, Wilson IJ, Bentham J, Darlay R, Töpf A, Zelenika D et al (2012) Contribution of global rare copy-number variants to the risk of sporadic congenital heart disease. Am J Hum Genet. 91(3):489–501PubMedPubMedCentralCrossRef Soemedi R, Wilson IJ, Bentham J, Darlay R, Töpf A, Zelenika D et al (2012) Contribution of global rare copy-number variants to the risk of sporadic congenital heart disease. Am J Hum Genet. 91(3):489–501PubMedPubMedCentralCrossRef
43.
Zurück zum Zitat McDaniell R, Warthen DM, Sanchez-Lara PA, Pai A, Krantz ID, Piccoli DA et al (2006) NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway. The American Journal of Human Genetics. 79(1):169–173PubMedCrossRef McDaniell R, Warthen DM, Sanchez-Lara PA, Pai A, Krantz ID, Piccoli DA et al (2006) NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway. The American Journal of Human Genetics. 79(1):169–173PubMedCrossRef
44.
Zurück zum Zitat Mori AD, Bruneau BG (2004) TBX5 mutations and congenital heart disease: Holt-Oram syndrome revealed. Curr Opin Cardiol. 19(3):211–215PubMedCrossRef Mori AD, Bruneau BG (2004) TBX5 mutations and congenital heart disease: Holt-Oram syndrome revealed. Curr Opin Cardiol. 19(3):211–215PubMedCrossRef
45.
Zurück zum Zitat Tartaglia M, Mehler EL, Goldberg R, Zampino G, Brunner HG, Kremer H, et al. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet. 2001;29(4).PubMedCrossRef Tartaglia M, Mehler EL, Goldberg R, Zampino G, Brunner HG, Kremer H, et al. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet. 2001;29(4).PubMedCrossRef
46.
Zurück zum Zitat Romano AA, Allanson JE, Dahlgren J, Gelb BD, Hall B, Pierpont ME et al (2010) Noonan syndrome: clinical features, diagnosis, and management guidelines. Pediatrics 126(4):746–759PubMedCrossRef Romano AA, Allanson JE, Dahlgren J, Gelb BD, Hall B, Pierpont ME et al (2010) Noonan syndrome: clinical features, diagnosis, and management guidelines. Pediatrics 126(4):746–759PubMedCrossRef
47.
Zurück zum Zitat Metcalfe K, Rucka AK, Smoot L, Hofstadler G, Tuzler G, McKeown P et al (2000) Elastin: mutational spectrum in supravalvular aortic stenosis. European journal of human genetics: EJHG. 8(12):955PubMedCrossRef Metcalfe K, Rucka AK, Smoot L, Hofstadler G, Tuzler G, McKeown P et al (2000) Elastin: mutational spectrum in supravalvular aortic stenosis. European journal of human genetics: EJHG. 8(12):955PubMedCrossRef
48.
Zurück zum Zitat Bauer RC, Laney AO, Smith R, Gerfen J, Morrissette JJ, Woyciechowski S et al (2010) Jagged1 (JAG1) mutations in patients with tetralogy of Fallot or pulmonic stenosis. Hum Mutat. 31(5):594–601PubMedPubMedCentralCrossRef Bauer RC, Laney AO, Smith R, Gerfen J, Morrissette JJ, Woyciechowski S et al (2010) Jagged1 (JAG1) mutations in patients with tetralogy of Fallot or pulmonic stenosis. Hum Mutat. 31(5):594–601PubMedPubMedCentralCrossRef
49.
Zurück zum Zitat McElhinney DB, Geiger E, Blinder J, Benson DW, Goldmuntz E. NKX2. 5mutations in patients with congenital heart disease. J Am coll cardiol. 2003;42(9):1650–5. McElhinney DB, Geiger E, Blinder J, Benson DW, Goldmuntz E. NKX2. 5mutations in patients with congenital heart disease. J Am coll cardiol. 2003;42(9):1650–5.
50.
Zurück zum Zitat Heathcote K, Braybrook C, Abushaban L, Guy M, Khetyar ME, Patton MA, et al. Common arterial trunk associated with a homeodomain mutation of NKX2. 6. Hum Mol Genet. 2005;14(5):585–93. Heathcote K, Braybrook C, Abushaban L, Guy M, Khetyar ME, Patton MA, et al. Common arterial trunk associated with a homeodomain mutation of NKX2. 6. Hum Mol Genet. 2005;14(5):585–93.
51.
Zurück zum Zitat Peng T, Wang L, Zhou S-F, Li X. Mutations of the GATA4 and NKX2. 5 genes in Chinese pediatric patients with non-familial congenital heart disease. Genetica. 2010;138(11–12):1231–40.PubMedCrossRef Peng T, Wang L, Zhou S-F, Li X. Mutations of the GATA4 and NKX2. 5 genes in Chinese pediatric patients with non-familial congenital heart disease. Genetica. 2010;138(11–12):1231–40.PubMedCrossRef
52.
Zurück zum Zitat Wei D, Bao H, Zhou N, Zheng G-F, Liu X-Y, Yang Y-Q (2013) GATA5 loss-of-function mutation responsible for the congenital ventriculoseptal defect. Pediatr Cardiol. 34(3):504–511PubMedCrossRef Wei D, Bao H, Zhou N, Zheng G-F, Liu X-Y, Yang Y-Q (2013) GATA5 loss-of-function mutation responsible for the congenital ventriculoseptal defect. Pediatr Cardiol. 34(3):504–511PubMedCrossRef
53.
Zurück zum Zitat Zheng G-F, Wei D, Zhao H, Zhou N, Yang Y-Q, Liu X-Y (2012) A novel GATA6 mutation associated with congenital ventricular septal defect. Int J Mol Med. 29(6):1065–1071PubMed Zheng G-F, Wei D, Zhao H, Zhou N, Yang Y-Q, Liu X-Y (2012) A novel GATA6 mutation associated with congenital ventricular septal defect. Int J Mol Med. 29(6):1065–1071PubMed
54.
Zurück zum Zitat Cheng Z, Wang J, Su D, Pan H, Huang G, Li X et al (2011) Two novel mutations of the IRX4 gene in patients with congenital heart disease. Hum Genet 130(5):657–662PubMedCrossRef Cheng Z, Wang J, Su D, Pan H, Huang G, Li X et al (2011) Two novel mutations of the IRX4 gene in patients with congenital heart disease. Hum Genet 130(5):657–662PubMedCrossRef
55.
Zurück zum Zitat Posch MG, Gramlich M, Sunde M, Schmitt KR, Lee SH, Richter S et al (2010) A gain-of-function TBX20 mutation causes congenital atrial septal defects, patent foramen ovale and cardiac valve defects. J Med Genet. 47(4):230–235PubMedPubMedCentralCrossRef Posch MG, Gramlich M, Sunde M, Schmitt KR, Lee SH, Richter S et al (2010) A gain-of-function TBX20 mutation causes congenital atrial septal defects, patent foramen ovale and cardiac valve defects. J Med Genet. 47(4):230–235PubMedPubMedCentralCrossRef
56.
Zurück zum Zitat Ware SM, Peng J, Zhu L, Fernbach S, Colicos S, Casey B et al (2004) Identification and functional analysis of ZIC3 mutations in heterotaxy and related congenital heart defects. Am J Hum Genet. 74(1):93–105PubMedCrossRef Ware SM, Peng J, Zhu L, Fernbach S, Colicos S, Casey B et al (2004) Identification and functional analysis of ZIC3 mutations in heterotaxy and related congenital heart defects. Am J Hum Genet. 74(1):93–105PubMedCrossRef
57.
Zurück zum Zitat Kasahara H, Lee B, Schott J-J, Benson DW, Seidman J, Seidman CE, et al. Loss of function and inhibitory effects of human CSX/NKX2. 5 homeoprotein mutations associated with congenital heart disease. J Clin Invest. 2000;106(2):299.PubMedPubMedCentralCrossRef Kasahara H, Lee B, Schott J-J, Benson DW, Seidman J, Seidman CE, et al. Loss of function and inhibitory effects of human CSX/NKX2. 5 homeoprotein mutations associated with congenital heart disease. J Clin Invest. 2000;106(2):299.PubMedPubMedCentralCrossRef
58.
Zurück zum Zitat Moskowitz IP, Wang J, Peterson MA, Pu WT, Mackinnon AC, Oxburgh L et al (2011) Transcription factor genes Smad4 and Gata4 cooperatively regulate cardiac valve development. Proc Natl Acad Sci 108(10):4006–4011PubMedCrossRef Moskowitz IP, Wang J, Peterson MA, Pu WT, Mackinnon AC, Oxburgh L et al (2011) Transcription factor genes Smad4 and Gata4 cooperatively regulate cardiac valve development. Proc Natl Acad Sci 108(10):4006–4011PubMedCrossRef
59.
Zurück zum Zitat Moskowitz IP, Kim JB, Moore ML, Wolf CM, Peterson MA, Shendure J et al (2007) A molecular pathway including Id2, Tbx5, and Nkx2-5 required for cardiac conduction system development. Cell 129(7):1365–1376PubMedCrossRef Moskowitz IP, Kim JB, Moore ML, Wolf CM, Peterson MA, Shendure J et al (2007) A molecular pathway including Id2, Tbx5, and Nkx2-5 required for cardiac conduction system development. Cell 129(7):1365–1376PubMedCrossRef
60.
Zurück zum Zitat Burdine RD, Schier AF (2000) Conserved and divergent mechanisms in left–right axis formation. Genes Dev. 14(7):763–776PubMed Burdine RD, Schier AF (2000) Conserved and divergent mechanisms in left–right axis formation. Genes Dev. 14(7):763–776PubMed
61.
Zurück zum Zitat Mohapatra B, Casey B, Li H, Ho-Dawson T, Smith L, Fernbach SD et al (2008) Identification and functional characterization of NODAL rare variants in heterotaxy and isolated cardiovascular malformations. Hum Mol Genet. 18(5):861–871PubMedPubMedCentralCrossRef Mohapatra B, Casey B, Li H, Ho-Dawson T, Smith L, Fernbach SD et al (2008) Identification and functional characterization of NODAL rare variants in heterotaxy and isolated cardiovascular malformations. Hum Mol Genet. 18(5):861–871PubMedPubMedCentralCrossRef
62.
Zurück zum Zitat Kosaki K, Kosaki R, Bassi M, Lewin M, Belmont J, Schauer G et al (1999) Characterization and mutation analysis of human LEFTY A and LEFTY B, homologues of murine genes implicated in left-right axis development. The American Journal of Human Genetics. 64(3):712–721PubMedCrossRef Kosaki K, Kosaki R, Bassi M, Lewin M, Belmont J, Schauer G et al (1999) Characterization and mutation analysis of human LEFTY A and LEFTY B, homologues of murine genes implicated in left-right axis development. The American Journal of Human Genetics. 64(3):712–721PubMedCrossRef
63.
Zurück zum Zitat Ching Y-H, Ghosh TK, Cross SJ, Packham EA, Honeyman L, Loughna S et al (2005) Mutation in myosin heavy chain 6 causes atrial septal defect. Nat Genet. 37(4):423–428PubMedCrossRef Ching Y-H, Ghosh TK, Cross SJ, Packham EA, Honeyman L, Loughna S et al (2005) Mutation in myosin heavy chain 6 causes atrial septal defect. Nat Genet. 37(4):423–428PubMedCrossRef
64.
Zurück zum Zitat Postma AV, van Engelen K, van de Meerakker J, Rahman T, Probst S, Baars MJ et al (2011) Mutations in the Sarcomere Gene MYH7 in Ebstein AnomalyClinical Perspective. Cir Cradiovas Genet. 4(1):43–50CrossRef Postma AV, van Engelen K, van de Meerakker J, Rahman T, Probst S, Baars MJ et al (2011) Mutations in the Sarcomere Gene MYH7 in Ebstein AnomalyClinical Perspective. Cir Cradiovas Genet. 4(1):43–50CrossRef
Metadaten
Titel
Genetic Contribution to Congenital Heart Disease (CHD)
verfasst von
NA Shabana
Saleem Ullah Shahid
Uzma Irfan
Publikationsdatum
01.01.2020
Verlag
Springer US
Erschienen in
Pediatric Cardiology / Ausgabe 1/2020
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-019-02271-4

Weitere Artikel der Ausgabe 1/2020

Pediatric Cardiology 1/2020 Zur Ausgabe

Ist Fasten vor Koronarinterventionen wirklich nötig?

Wenn Eingriffe wie eine Koronarangiografie oder eine Koronarangioplastie anstehen, wird häufig empfohlen, in den Stunden zuvor nüchtern zu bleiben. Ein französisches Forscherteam hat diese Maßnahme hinterfragt.

PET kann infarktgefährdete Koronararterien entdecken

04.06.2024 Koronare Herzerkrankung Nachrichten

Der Nachweis aktiver Plaques mittels 18F-Natriumfluorid-PET hilft nicht nur, infarktgefährdete Patienten, sondern auch infarktgefährdete Koronararterien zu erkennen. Von einer gezielten Behandlung vulnerabler Plaques ist man trotzdem weit entfernt.

GLP-1-Agonist Semaglutid wirkt kardio- und nephroprotektiv

03.06.2024 Semaglutid Nachrichten

Der GLP-1-Agonist Semaglutid hat in der FLOW-Studie bewiesen, dass sich damit die Progression chronischer Nierenerkrankungen bei Patienten mit Typ-2-Diabetes bremsen lässt. Auch in kardiovaskulärer Hinsicht war die Therapie erfolgreich.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.